About Linear Health Sciences
Linear Health Sciences is a company based in Oklahoma City (United States) founded in 2015. Linear Health Sciences has raised $1.5 million across 1 funding round from investors including i2E. Linear Health Sciences offers products and services including Orchid SRV. Linear Health Sciences operates in a competitive market with competitors including 410 Medical, Hospira, Ivenix, Belmont Medical Technologies and IRadimed, among others.
- Headquarter Oklahoma City, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.5 M (USD)
in 1 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Dec 12, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Linear Health Sciences
Linear Health Sciences offers a comprehensive portfolio of products and services, including Orchid SRV.
Device that prevents IV dislodgements in medical tubing for patient safety.
People of Linear Health Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Linear Health Sciences
Linear Health Sciences has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.5 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linear Health Sciences
Linear Health Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include i2E.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & Angel networks focused on science and tech startups
|
Locked | Locked | Locked |
Investor details for Linear Health Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linear Health Sciences
Investment portfolio details for Linear Health Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linear Health Sciences
Detailed financials for Linear Health Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linear Health Sciences Comparisons
Peer comparison for Linear Health Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linear Health Sciences
Linear Health Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 410 Medical, Hospira, Ivenix, Belmont Medical Technologies and IRadimed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Rapid infusion systems are provided for critically ill patients.
|
|
| Locked | Locked | Locked |
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Infusion management systems are developed with wireless web-based architecture.
|
|
| Locked | Locked | Locked |
Fluid management and critical care medical devices are developed.
|
|
| Locked | Locked | Locked |
Developer of IV Infusion system and patient monitoring systems for the MRI setting
|
|
| Locked | Locked | Locked |
Medical devices for infusion therapy, monitoring, and radiology are manufactured.
|
Detailed competitors of Linear Health Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linear Health Sciences
Complete news archive for Linear Health Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linear Health Sciences
Linear Health Sciences was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Linear Health Sciences is headquartered in Oklahoma City, United States. It is registered at Oklahoma City, Oklahoma, United States.
Linear Health Sciences is a funded company, having raised a total of $1.5M across 1 funding round to date.
Linear Health Sciences was founded in 2015 and is based in Oklahoma City, United States. Medical devices focused on IV dislodgement prevention are developed, including the patent-pending Orchid SRV IV breakaway valve. A scalable platform technology is utilized across various medical tubing applications. As of February 2017, the Orchid valve has not been approved by the FDA. Operations center on enhancing patient safety in intravenous therapy.
Linear Health Sciences's top competitors include 410 Medical, IRadimed and Belmont Medical Technologies.
Linear Health Sciences offers Orchid SRV.
Linear Health Sciences has 1 investor. Key investors include i2E.